Streetbeat News

AKLI

Akili Inc

Industry

Data Processing, Hosting, and Related Services

Open

0.43

Mkt cap

34M

Volume

236K

High

0.43

P/E Ratio

-0.71

52-wk high

1.25

Low

0.43

Div yield

N/A

52-wk low

0.19

Akili announces that EndeavorOTC is the only FDA-authorized digital therapeutic for ADHD available without a prescription. This product aims to improve attention function in individuals with ADHD through a video game experience.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 8:10 pm

Akili has received FDA clearance for EndeavorOTC (AKL-T01) as an over-the-counter treatment for adults with Attention-deficit/Hyperactivity Disorder (ADHD).

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 8:02 pm

Trading for AKLI was halted and then resumed at 8:25:00 AM ET. The halt was due to news pending, and trading has now resumed.

Portfolio Pulse from Benzinga Newsdesk

May 29, 2024 | 12:25 pm

PureTech Health has announced a merger agreement between Akili and Virtual Therapeutics to form a leading digital health company.

Portfolio Pulse from Benzinga Newsdesk

May 29, 2024 | 12:11 pm

Trading in AKLI was halted at 7:57:37 a.m. ET due to pending news. Investors should stay tuned for further updates.

Portfolio Pulse from Benzinga Newsdesk

May 29, 2024 | 11:57 am

Akili reported Q1 2024 adjusted EPS of $(0.12), beating the $(0.14) estimate, but missed sales estimates with $383.00K versus the expected $794.00K. Despite the sales miss, this represents a significant increase over the previous year's figures.

Portfolio Pulse from Benzinga Newsdesk

May 14, 2024 | 8:41 pm

The article reports on the movement of health care stocks in Tuesday's after-market session, highlighting both gainers and losers based on their Q1 earnings reports. Arcutis Biotherapeutics, BioAtla, OptimizeRx, Psyence Biomedical, Bone Biologics, and SINTX Techs saw gains, while Bolt Biotherapeutics, Vivos Therapeutics, Iridex, Prestige Consumer, Akili, and Ocean Biomedical experienced declines.

Portfolio Pulse from Benzinga Insights

May 14, 2024 | 8:31 pm

Akili is exploring potential strategic alternatives to enhance shareholder value, which may include partnerships, a sale, or other options. This decision reflects the company's commitment to maximizing its assets and strategic position.

Portfolio Pulse from Benzinga Newsdesk

May 14, 2024 | 8:24 pm

H&E Equipment Services, Inc. (HEES) shares fell by 18.2% following mixed Q1 results, missing EPS estimates but beating sales expectations. Other stocks experienced significant movements, with notable gainers including Akili, Inc. (AKLI) and losers like Lichen China Limited (LICN). Various companies reported financial results, strategic partnerships, and other business updates affecting their stock prices.

Portfolio Pulse from Avi Kapoor

April 30, 2024 | 5:24 pm

The Nasdaq Composite fell over 100 points amid lower U.S. stock trading, with Coca-Cola Company reporting better-than-expected Q1 results. Health care shares slightly rose, while energy shares dropped significantly. Akili, AGBA Group Holding, and Global Mofy Metaverse saw their stocks surge on positive developments, whereas Chegg, Vince Holding, and Medifast experienced significant declines following their financial results.

Portfolio Pulse from Avi Kapoor

April 30, 2024 | 4:34 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.